Mistletoe lectin-I augments antiproliferative effects of the PPARγ agonist rosiglitazone on human malignant melanoma cells

Phytotherapy Research

Volumn 24, Issue 9, 2010, Pages 1354-1358

  Freudlsperger, Christian ^a,b   Dahl, Anka ^a   Hoffmann, Juergen ^b   Reinert, Siegmar ^b   Schumacher, Udo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chemotherapy; Combination therapy; Drug interaction; Malignant melanoma; Mistletoe; PPAR

Indexed keywords

ROSIGLITAZONE; VISCUM ALBUM LECTIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; MELANOMA; VISCUM ALBUM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MELANOMA; PHYTOTHERAPY; PLANT EXTRACTS; PPAR GAMMA; RIBOSOME INACTIVATING PROTEINS, TYPE 2; THIAZOLIDINEDIONES; TOXINS, BIOLOGICAL; VISCUM ALBUM;

EID: 77957284996     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3122     Document Type: Article

References (35)

1. Augustin M, Bock P, Hanisch J, Karasmann M, Schneider B. 2005. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung 55: 38-49.
2. Burger A, Mengs U, Kelter G, Schüler J, Fiebig H. 2003. No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro. Anticancer Res 23: 3801-3806. (Pubitemid 37474327)
3. Burger AM, Mengs U, Schuler JB, Fiebig HH, Kelter G. 2001. Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro. No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro. Arzneimittelforschung 51: 748-757.
4. Burstein HJ, Demetri GD, Mueller E, Sarraf P, Spiegelman BM, Winer EP. 2003. Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: A phase II study. Breast Cancer Res Treat 79: 391-397.
5. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K. 1996. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 99: 59-72. (Pubitemid 26030353)
6. Debrock G, Vanhentenrijk V, Sciot R, Debiec-Rychter M, Oyen R, Van Oosterom A. 2003. A phase II trial with rosiglitazone in liposarcoma patients. Br J Cancer 89: 1409-1412. (Pubitemid 37386592)
7. Demetri GD, Fletcher CDM, Mueller E et al. 1999. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96: 3951-3956.
8. Eastham L, Mills C, Niles R. 2008. PPAR alpha/gamma expression and activity in mouse and human melanocytes and melanoma cells. Pharm Res 25: 1327-1333.
9. Edward M. 2001. Melanoma cell-derived factors stimulate glycosaminoglycan synthesis by fibroblasts cultured as monolayers and within contracted collagen lattices. Br J Dermatol 144: 465-470. (Pubitemid 32231998)
10. Elstner E, Müller C, Koshizuka K et al. 1998. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95: 8806-8811.
11. Fodstad O, Kjonniksen I, Aamdal S, Nesland JM, Boyd MR, Pihl A. 1988. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res 48: 4382-4388.
12. Freudlsperger C, Moll I, Schumacher U, Thies A. 2006. Antiproliferative effect of peroxisome proliferator-activated receptor γ agonists on human malignant melanoma cells in vitro. Anti-Cancer Drugs 17: 325-332.
13. Gabius H, Darro F, Remmelink M et al. 2001. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer Invest 19: 114-126.
14. Girnun GD, Naseri E, Vafai SB et al. 2007. Synergy between PPAR gamma ligands and platinum-based drugs in cancer. Cancer Cell 11: 395-406. (Pubitemid 46670076)
15. Guan Y, Zhang Y, Breyer R, Davis L, Breyer M. 1999. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Neoplasia 1: 330-339.
16. Horneber M, Bueschel G, Huber R, Linde K, Rostock M. 2008. Mistletoe therapy in oncology. Cochrane Database Syst Rev: CD003297.
17. Jemal A, Siegel R, Ward E et al. 2008. Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
18. Kubota T, Koshizuka K, Williamson EA et al. 1998. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58: 3344-3352. (Pubitemid 28371075)
19. Kulke MH, Demetri GD, Sharpless NE et al. 2002. A phase II study of troglitazone, an activator of the PPAR gamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer. Cancer J 8: 395-399.
20. Lee C, Ramirez J, Guitart J, Diaz L. 2008. Expression of cyclooxygenase- 2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression. J Cutan Pathol 35: 989-994.
21. Lee SY, Hur GY, Jung KH et al. 2006. PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression. Lung Cancer 51: 297-301.
22. Mössner R, Schulz U, Krüger U et al. 2002. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol 119: 576-582.
23. Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y. 2000. Activation of peroxisome proliferator-activated receptor ã by troglitazone inhibits cell growth through the increase of p27(Kip1) in human pancreatic carcinoma cells. Cancer Res 60: 5558-5564.
24. Mueller E, Smith M, Sarraf P et al. 2000. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci USA 97: 10990-10995.
25. Núñez N, Liu H, Meadows G. 2006. PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells. Cancer Lett 236: 133-141. (Pubitemid 44419327)
26. Philips JC, Petite C, Willi JP, Buchegger F, Meier CA. 2004. Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers. Nucl Med Commun 25: 1183-1186. (Pubitemid 39614279)
27. Placha W, Gil D, Dembiñska-Kiec' A, Laidler P. 2003. The effect of PPAR gamma ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res 13: 447-456. (Pubitemid 37266947)
28. Reichle A, Vogt T, Coras B et al. 2007. Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: A randomized phase II trial. Melanoma Res 17: 360-364.
29. Sarraf P, Mueller E, Jones D et al. 1998. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nature Med 4: 1046-1052.
30. Sato H, Ishihara S, Kawashima K et al. 2000. Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists. Br J Cancer 83: 1394-1400.
31. Smalley KSM, Haass NK, Brafford PA, Lioni M, Flaherty KT, Herlyn M. 2006. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther 5: 1136-1144. (Pubitemid 43881305)
32. Soengas M, Lowe S. 2003. Apoptosis and melanoma chemoresistance. Oncogene 22: 3138-3151.
33. Stein G, Schietzel M, Büssing A. 1998. Mistletoe in immunology and the clinic (short review). Anticancer Res 18: 3247-3249. (Pubitemid 28546441)
34. Thies A, Nugel D, Pfüller U, Moll I, Schumacher U. 2005. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. Toxicology 207: 105-116. (Pubitemid 39601690)
35. Tsubouchi Y, Sano H, Kawahito Y et al. 2000. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun 270: 400-405.